GlassScriptPhysician profile
Jeffrey Wallentine
NPI 1124121934
$19,227.64
in general payments reported to CMS, 2019-2025
21 companies · $687 in 2025
The $687 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,826 · 2020: $3,309 · 2021: $4,154 · 2022: $4,194 · 2023: $460 · 2024: $3,598 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,899 · Food and Beverage: $1,845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,899.48 |
| Food and Beverage | $1,845.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Active Medical, LLC | $7,777.64 | 2019-2024 | |
| Arthrex, INC. | $7,220.20 | 2019-2024 | |
| Stryker Corporation | $2,386.04 | 2019-2025 | Mako, Triathlon, Insignia |
| Zimmer Biomet Holdings, INC. | $1,143.69 | 2022-2023 | Persona |
| Innovation Technologies INC | $118.86 | 2020 | |
| Medical Device Business Services, INC. | $99.23 | 2025 | Vistaseal |
| Astellas Pharma US INC | $78.04 | 2024-2025 | Vyloy, Xospata |
| Boston Scientific Corporation | $66.79 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Bioventus LLC | $52.18 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Sanofi-Aventis U.S. LLC | $46.78 | 2019-2023 | |
| Globus Medical, INC. | $39.14 | 2024 | Ankle Fracture System, Clavicular Fracture Fixation |
| Ferring Pharmaceuticals INC. | $28.66 | 2021-2023 | Euflexxa |
| Pfizer INC. | $26.74 | 2019-2021 | |
| Averitas Pharma INC. | $24.03 | 2024 | Qutenza |
| Abbvie INC. | $22.39 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.97 | 2024 | Relistor |
| Depuy Synthes Sales INC. | $20.27 | 2019 | |
| Amgen INC. | $15.63 | 2019 | |
| Abbott Laboratories | $14.63 | 2022 | |
| Relievant Medsystems, INC. | $12.98 | 2023 | Intracept |
| Kci USA, INC. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Wallentine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.